Profile data is unavailable for this security.
About the company
Mono Pharmacare Ltd is an India-based company, which is a distributor and supplier of a wide array of pharmaceutical products and medicines. The company offers health care products, antibiotic medicines, cough, cold-anti-allergic medicines, antifungal medicines, nutraceutical medicines, analgesic and antipyretic medicines, antacid and antiemetics medicines, cardiac - diabetic medicines, and Cosmo care products. The Company’s segments are Marketing of Pharmaceutical Products, and Distributor of Pharmaceuticals Companies. Its portfolio comprises a wide range of drugs like antibiotics, antifungal, anti-cough cold and anti-allergic, antacid and antiemetics, analgesics and antipyretics, nutraceuticals, skincare, antiseptic, cardiac and diabetic and cosmetics.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2022
- Employees--
- LocationMono Pharmacare LtdAHMEDABAD 380007IndiaIND
- Websitehttps://monopharmacareltd.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vineet Laboratories Ltd | 1.51bn | 10.27m | 542.08m | -- | 52.97 | 1.56 | 15.29 | 0.36 | 1.11 | 1.11 | 163.46 | 37.67 | 1.29 | 2.38 | 4.51 | -- | 0.8826 | -- | 2.50 | -- | 24.35 | -- | 0.682 | -- | 0.5105 | 0.9792 | 0.5606 | -- | -29.06 | -- | -18.00 | -- | -- | -- |
JFL Life Sciences Ltd | -100.00bn | -100.00bn | 621.41m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.63 | -- | 50.42 | -- | -- | -- |
Mono Pharmacare Ltd | -100.00bn | -100.00bn | 699.68m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 58.12 | -- | 251.10 | -- | -- | -- |